Insurance - Life · NYSE
Current Price
$95.67
PE Ratio (TTM)
12.4x
Intrinsic Value
$130
+26.4% margin of safety
COMPETITIVE MOAT
↑Brand Recognition and Trust
MetLife benefits from a long-standing reputation for financial strength and reliability. This established trust is crucial for attracting and retaining customers in the life insurance sector.
↑Scale and Diversified Business
The company's large operational scale allows for cost efficiencies and a broad product offering. Diversification across different insurance lines and geographies mitigates risk.
↑Actuarial Expertise and Data
Deep actuarial knowledge and extensive historical data enable sophisticated risk assessment and pricing. This analytical advantage is difficult for smaller competitors to replicate.
INVESTMENT RISKS
↓Interest Rate Sensitivity
MetLife's investment portfolio is sensitive to interest rate fluctuations. Declining rates can negatively impact investment income and profitability.
↓Underwriting and Mortality Risk
Unexpected increases in mortality rates or higher-than-anticipated claims can significantly affect financial results. Accurate actuarial assumptions are critical.
↓Economic Downturns
Recessions can lead to reduced demand for insurance products and increased policy lapses. Economic instability poses a threat to premium growth and investment returns.
Base case
A base case PE valuation for MET estimates a fair value of about $130 per share, against a current price of $95.67. The model assumes 8.9% annual earnings growth, a 11.86x target PE multiple, and a 10% discount rate.
Intrinsic Value
$130
Margin of safety
+26.4%
Expected annual return
+6.3%
Base case assumptions: 8.9% annual earnings growth, 11.86x target PE, 10% discount rate, 5 year projection. Data as of 2026-11-20.
This base case uses default assumptions and is not financial advice. The fair value changes significantly when the target PE or earnings growth rate changes. Open the calculator to set your own assumptions and see the full sensitivity range.
Adjust the target PE, earnings growth, and discount rate to see how the fair value and margin of safety for MetLife, Inc. respond.
Open PE Calculator for METMetLife, Inc. operates as a leading global financial services entity, delivering an extensive array of services encompassing insurance, annuities, employee benefits, and asset management. The company manages its operations through five primary divisions: the U.S., Asia, Latin America, Europe, the Middle East and Africa (EMEA), and MetLife Holdings. Its broad insurance offerings include life, dental, group short-term and long-term disability, individual disability, pet, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans. MetLife also supports employers with administrative services-only (ASO) arrangements. Furthermore, it provides sophisticated financial instruments such as general and separate account contracts, synthetic guaranteed interest contracts, and private floating rate funding agreements. The company facilitates pension risk transfers, offers institutional income annuities, structures settlements, and delivers capital markets investment products. Specialized life insurance products and funding agreements are also available for post-retirement benefits, alongside company, bank, or trust-owned life insurance used to finance non-qualified executive benefit programs. In addition, MetLife offers a variety of annuity options including fixed, indexed-linked, and variable, alongside pension and regular savings products. Its life insurance portfolio features whole life, term life, endowments, universal and variable life, and group life policies. The company also provides longevity reinsurance solutions, credit insurance products, and protection for long-term healthcare services. MetLife, Inc. was founded in 1863 and is headquartered in New York City.
PE Ratio (TTM)
12.4x
PEG Ratio
0.28
Earnings Yield
8.44%
ROE (TTM)
19.5%
Revenue/Share (TTM)
$129.59
Dividend Yield
2.45%
Debt/Equity
0.98x
The trailing twelve-month PE ratio of MET reflects how much investors pay per dollar of MetLife, Inc.'s earnings. This metric is most useful when compared to Insurance - Life peers and the company's own historical range.
MET's PE of 12.4x combined with a PEG ratio of 0.28 provides a growth-adjusted perspective. A PEG below 1.0 means the P/E is low relative to the earnings growth rate. Keep in mind that PE-based valuation works best for profitable, mature companies — for high-growth or cyclical Insurance - Life, a DCF analysis may be more appropriate.
To value MetLife, Inc. using PE: (1) Compare the current PE (12.4x) against the Insurance - Life median to assess relative pricing, (2) check the PEG ratio (0.28) to adjust for growth expectations, (3) review the 5-year PE range to identify where the stock sits historically, and (4) estimate fair value by multiplying a target PE by forward EPS estimates. This relative approach complements DCF's absolute valuation.
MET's PEG ratio is 0.28, calculated by dividing the PE ratio (12.4x) by the expected earnings growth rate. A PEG below 1.0 means the P/E is low relative to the expected earnings growth rate. Note that PEG accuracy depends on the reliability of growth estimates.
PE ratio gives a quick relative read — how MET is priced versus Insurance - Life peers. DCF provides an absolute value based on projected free cash flows. For MET, with a strong ROE of 19.5%, both methods are worth using — PE for a market-relative check, DCF to stress-test whether fundamentals justify the price. Each method has blind spots: PE ignores capital structure and cash flow quality, while DCF is sensitive to growth and discount rate assumptions.
P/E and DCF value MET with different methods and assumptions, so the two conclusions can differ. Compare the DCF intrinsic value.
Price as of 2026-11-20. Financial data from Financial Modeling Prep (trailing twelve months) · Valuation methodology by Charlie Wang.
This is an estimate, not investment advice.